Counterfeit products in the pharmaceutical industry can have serious consequences for customers and consumers alike – so what can be done to nip them in the bud? David DeJean, vice president of global strategic accounts at Systech, explains how regulation, serialization, traceability, and developing technologies can help.
Become a subscriber to read this story, as well as other exclusive articles and interviews. The process is entirely free and takes no time at all.